Search

In-Vivo Electrophysiological Study of Induced Ventricular Tachycardia in Intact Rat Model of Chronic Ischemic Heart Failure

IN-VIVO ELECTROPHYSIOLOGICAL STUDY OF INDUCED VENTRICULAR TACHYCARDIA IN INTACT RAT MODEL OF CHRONIC ISCHEMIC HEART FAILURE

Ventricular tachycardia and ventricular fibrillation are the most common causes of sudden cardiac death in patients with chronic heart...

 
 
 
BIO 2017 Innovation Zone Company Snapshot: Xeris Pharmaceuticals, Inc

BIO 2017 INNOVATION ZONE COMPANY SNAPSHOT: XERIS PHARMACEUTICALS, INC

The next big medical breakthrough may start in a small business with a big idea. Recognizing the potential and promise of early-stage...

 
 
 

NEKTAR PENS SWEETENED TAKEDA CANCER DRUGS DEAL

Perennial biotech investor and backer Takeda has signed its latest collaboration with Nektar Therapeutics that will see the pair work...

Life After Start-Up Stadium: SyntheX, Inc

LIFE AFTER START-UP STADIUM: SYNTHEX, INC

For the third year, the BIO International Convention will host the 2017 BIO Start-Up Stadium Empowering the Cutting-Edge Companies...

 
 
 
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny

EX-SAREPTA CEO GARABEDIAN RETURNS TO RUN BIO ACCELERATOR XONTOGENY

Chris Garabedian, a veteran biotech executive who helped turn Sarepeta Therapeutics around before his controversial exit in 2015, has...

 
 
 
BIO 2017 Innovation Zone Company Snapshot: NuvOx Pharma

BIO 2017 INNOVATION ZONE COMPANY SNAPSHOT: NUVOX PHARMA

The next big medical breakthrough may start in a small business with a big idea. Recognizing the potential and promise of early-stage...

Austin's MAP Health Teams Up With Watson For Better Data Analytics

AUSTIN'S MAP HEALTH TEAMS UP WITH WATSON FOR BETTER DATA ANALYTICS

Austin -MAP Health Management, an Austin health IT and telehealth company, is partnering with IBM Watson to use analytics to better...

 
 
 
Synlogic And Its Modified Bacteria Take Over Dying Company, Go Public

SYNLOGIC AND ITS MODIFIED BACTERIA TAKE OVER DYING COMPANY, GO PUBLIC

Synlogic, which is developing modified bacteria to use as medicine, has gone public in an unconventional way. Instead of hiring Wall...

CLINICAL RESULTS OF DRUG-FREE FREESPIRA® TREATMENT FOR PANIC TO BE PRESENTED AT CLINICAL TMS SOCIETY ANNUAL MEETING

Multi-center naturalistic study validates prior academic study DANVILLE, Calif., May 15, 2017 /PRNewswire/ - Palo Alto Health Sciences,...

 
 
 
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer

BIO LEADERS MOURN PASSING OF GENZYME EXEC, ORPHAN DRUG INNOVATOR TERMEER

Henri Termeer, a biotechnology pioneer and the longtime CEO of Genzyme, has passed away at the age of 71. According to the Boston Globe...

 
 
 

ASSOCIATE SALES CONSULTANT - FORT SMITH, AR KYA09762

At Quintiles we help healthcare and biopharma companies improve their probability of success. We do this by connecting our scientific,...

 
 
 
Pfizer and Sangamo ink a $545M hemophilia-gene therapy deal

PFIZER AND SANGAMO INK A $545M HEMOPHILIA-GENE THERAPY DEAL

Pfizer has doubled-down on a gene therapy approach to treating hemophilia, announcing a new deal with Sangamo Therapeutics that could...

AUDENTES THERAPEUTICS ANNOUNCES APPOINTMENT OF JOHN T. GRAY, PH.D. TO SENIOR VICE PRESIDENT AND CHIEF SCIENTIFIC OFFICER

SAN FRANCISCO, May 8, 2017 /PRNewswire/ - Audentes Therapeutics, Inc. , a biotechnology company focused on developing and commercializing...

 
 
 
Four Seasons Hotel St. Louis Celebrates Global Wellness Day on June 10

FOUR SEASONS HOTEL ST. LOUIS CELEBRATES GLOBAL WELLNESS DAY ON JUNE 10

Four Seasons Hotel St. Louis will celebrate Global Wellness Day on Saturday, June 10, 2017 with sunrise yoga followed by a healthy...